Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
100.00%
Operating Margin
88.87%
Net Margin
127.17%

Efficiency Metrics

Revenue per Expense Ratio
8.99
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
2.3000000000

Balance Sheet Analysis

Current Ratio
19.25
Cash Ratio
0.65
Working Capital
$10.95M
Debt to Equity
0.60
Debt to Assets
37.30%
Equity Ratio
62.39%

Cash Flow Analysis

Operating Cash Flow Ratio
77.09%
Free Cash Flow Ratio
77.09%
CapEx to Revenue
0.00%
Dividends Paid
$36.95M
Stock Buybacks
No buybacks
Total Shareholder Returns
$36.95M
Cash Position Change
67.60%

Key Takeaways (2024 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
255.10%
Net Income
294.03%
EPS
293.28%
Operating Income
235.59%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
1,132.17%
Operating Cash Flow
0.45%
Free Cash Flow
0.45%

Balance Sheet Health

Assets
3.75%
Debt
0.00%
Book Value per Share
5.36%
Inventory
100.00%

Shareholder Returns

Dividends per Share
-0.83%
Shares Outstanding
0.59%

Long Term Trends

3Y Revenue/Share
-53.46%
5Y Revenue/Share
5.21%
3Y Dividend/Share
-2.39%
5Y Dividend/Share
-15.34%